Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Indivior Plc ADR
(OP:
INVVY
)
N/A
UNCHANGED
Last Price
Updated: 10:23 AM EDT, Jun 9, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Indivior Plc ADR
Indivior Reaches $102.5M Settlement To Resolve Antitrust Litigation
June 05, 2023
Indivior PLC (OTCPK:INVVY) (OTCPK:IZQVF) (LSE: NDV), an addiction treatment company, announced that its subsidiary, Indivior Inc., has reached an agreement to resolve the claims brought by the...
Via
Benzinga
Activist Investor Recommends Yelp Explore Sale, Micron Projects China Ban To Curb Revenues, Spruce Point Capital Raises Concerns About Perion Network's Financial Practices: Today's Top News
May 23, 2023
Wall Street Journal
Via
Benzinga
Nasal-Spray Millionaire: Indivior's Opvee Nasal Spray Gets FDA Green Light for Opioid Overdose Treatment
May 23, 2023
The FDA has approved Indivior PLC's (OTC: INVVY) Opvee (nalmefene) nasal spray for the emergency treatment of opioid overdose in adults and pediatric patients aged 12 years and older.
Via
Benzinga
Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio
March 03, 2023
Indivior PLC (OTCPK:INVVY) (LSE:INDV) has completed the acquisition of Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) The transaction strengthens Indivior's addiction treatment and science portfolio by...
Via
Benzinga
Indivior Targeting Listing On NASDAQ For The Spring Of 2023
December 07, 2022
Indivior PLC (OTCPK:INVVY) (LON:INDV) will hold a capital markets day on December 7th in New York City. The event will be hosted by Mark Crossley, CEO, along with members of the Indivior executive...
Via
Benzinga
Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14
November 14, 2022
Reuters
Via
Benzinga
Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals
November 14, 2022
Via
Benzinga
Hypocrisy All Around: Pfizer, NFL Are Hidden Sponsors Of Anti-Drug Group Fighting Against Cannabis Legalization
August 17, 2022
The Community Anti-Drug Coalitions of America (CADCA), which is fighting against federal cannabis legalization, recently removed a page on its website disclosing its partners.
Via
Benzinga
Indivior Positioned To Profit If Aelis Farma's Study Of Cannabis Use Disorder Succeeds
June 01, 2022
Indivior PLC (OTCPK:INVVY) (LON:INDV) announces the enrollment of the first patient in the Phase 2b study of AEF0117 for the treatment of cannabis use disorder (CUD).
Via
Benzinga
Indivior Study Shows Buprenorphine May Mitigate Fentanyl-Induced Respiratory Depression In Chronic Opioid Users
April 11, 2022
Indivior PLC (OTCPK:INVVY) (LON:INDV) published modeling data examining the competitive interaction between buprenorphine, a treatment for opioid use disorder, and fentanyl, a potent synthetic opioid,...
Via
Benzinga
Cannabis Movers & Shakers: MedMen, IM Cannabis, Avicanna, Avant Brands
January 13, 2022
MedMen's CRO Tracy McCourt Named President Of Emerald Village West Hollywood Cannabis retailer MedMen Enterprises Inc.
Via
Benzinga
Using Opioid Addiction Drug Buprenorphine May Cause Dental Issues, FDA Flags
January 13, 2022
The FDA warned patients and prescribers about the risk of potential dental problems arising from the use of buprenorphine medicines to treat opioid addiction and pain....
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.